These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3275069)

  • 21. Late oral complications following radiotherapy for head and neck cancers.
    Chua DT; Tian Y; Wei WI
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1215-24. PubMed ID: 17892422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
    Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
    Allal AS; Maire D; Becker M; Dulguerov P
    Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
    Altmann S; Hoffmanns H
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
    MacDermed D; Thurber L; George TI; Hoppe RT; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):788-95. PubMed ID: 15183482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
    Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
    Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of proton beam radiation therapy in head and neck cancer.
    Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
    Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Radiation Therapy Oncology Group].
    Herrmann T
    Strahlenther Onkol; 1995 Apr; 171(4):244-5. PubMed ID: 7740414
    [No Abstract]   [Full Text] [Related]  

  • 32. The Toronto philosophy of management in head and neck cancer.
    Rider WD; Harwood AR
    J Otolaryngol; 1982 Feb; 11(1):14-6. PubMed ID: 7077720
    [No Abstract]   [Full Text] [Related]  

  • 33. Future issues in highly conformal radiotherapy for head and neck cancer.
    Feng M; Eisbruch A
    J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHART revisited: a conservative approach for advanced head and neck cancer.
    Saunders M; Rojas AM; Dische S
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actual versus ideal treatment time in radiotherapy for head and neck cancer: catching up with the gaps.
    Bentzen SM; Overgaard M
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):687-8. PubMed ID: 7726932
    [No Abstract]   [Full Text] [Related]  

  • 37. Discontinuous accelerated fractionation in the treatment of advanced head and neck neoplasms--a preliminary report.
    Huilgol NG; Savithri S; Metha AR
    Acta Oncol; 1993; 32(1):84. PubMed ID: 8466771
    [No Abstract]   [Full Text] [Related]  

  • 38. Proton therapy for head neck cancer.
    Mali SB
    Oral Oncol; 2015 Feb; 51(2):e10-2. PubMed ID: 25467208
    [No Abstract]   [Full Text] [Related]  

  • 39. Fraction size or accelerated repopulation?
    Schwaibold F; Taylor JM
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1656. PubMed ID: 2722609
    [No Abstract]   [Full Text] [Related]  

  • 40. The inconclusive role of treatment time in radiotherapy of head and neck tumours.
    Dubben HH
    Radiother Oncol; 1995 Mar; 34(3):229-30. PubMed ID: 7631030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.